Results showed that exposure to metformin was associated with a reduced risk for nonmelanoma skin cancer across skin types diagnosed with SCC and BCC with multivariable adjusted odds ratios of 0. ...

A common drug used to treat type 2 diabetes can be a “protective agent against non-melanoma skin cancer”, a new study has shown.. Researchers have found that people using metformin are less at risk of ...

Metformin use and risk of non-melanoma skin cancer: a propensity-matched case-control study. J Drugs Dermatol . 2024;23(12):1089-1095. doi:10.36849/jdd.8249 Key statistics for basal and squamous ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of skin tumor organoids. This research highlights metformin’s role in ...

People With Diabetes Who Stop Taking Metformin Face Increased Dementia Risk. Written by Gigen Mammoser on October 25, 2023 — Fact checked by Jill Seladi-Schulman, Ph.D.